DuPont expands biopharma tubing manufacturing capabilities

The launch of DuPont’ new biopharma tubing manufacturing site in the US marks a key milestone in company’s healthcare growth strategy.

DuPont recently celebrated the opening of its new DuPont Liveo Healthcare Solutions manufacturing facility located at the Cooper River Site in South Carolina, US. The formal ribbon-cutting ceremony was attended by state and government officials and business leaders. The new facility will expand capacity for biopharmaceutical tubing extrusion to meet increased demand from Liveo customers.

The site uses the same quality standards as the DuPont Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan. This is DuPont’s long-standing healthcare manufacturing site. Operators at the new South Carolina facility have been certified at HIMS.

“Over the next two years, the Cooper River site will bring additional production capacity online to serve strategic customers and expand our Liveo Healthcare Solutions customer base,” says DuPont Healthcare & Specialty Lubricants global business director, Eugenio Toccalino. “We’re committed to investing in our healthcare business, and this biopharma processing manufacturing investment at Cooper River is a key milestone in our growth strategy that will help us offer a highly reliable and sustainable product supply.”

DuPont worked with companies from the area including more than 40 subcontractors on the site expansion project.

Core values and commitment

“Being selected as the second dedicated healthcare site is indeed an honour and a reflection of our team’s track record of dedication, ownership and commitment to our core values and excellence in meeting customers’ needs. Thanks to collaboration between the DuPont team and our contractor partners, the Cooper River site was completed within 17 months – on time, on budget and without a single recordable safety incident,” said Bill Alexander, DuPont Cooper River site leader. “The opening of the site already has enabled the creation of 25 jobs for startup, with another 25 expected by mid-2024 as we ramp up operations.”

DuPont is demonstrating its commitment to serving the healthcare market and its customers with this expansion of its manufacturing footprint, offering high-quality, high-performance solutions, and supporting regulatory actions that address healthcare customers’ specific needs and challenges.

In addition to the Cooper River expansion, in the second half of 2022, the company expects to add biopharma silicone tubing capacity in China to serve the fast-growing customers in that region.